Verdict
Pros
- Flat $178/mo at every dose, the only program in the chart that holds the price as you titrate up.
- True month-to-month with online self-serve cancellation, no retention call.
- Compounded semaglutide path for cash-pay patients without insurance friction.
- Three-day average time to first prescription via video visit.
- HSA and FSA accepted.
Cons
- Compounded only on cash-pay; branded Wegovy and Zepbound are insurance-only.
- Lost a partner pharmacy in 2025 to FDA enforcement on unsafe compounding.
- Active in Lilly's compounded-tirzepatide litigation. Supply continuity is not guaranteed.
- Not available in Louisiana or Mississippi.
- Members report shipping delays during demand spikes.
Cash-pay patients who want predictable monthly pricing and a compounded GLP-1 path.
Patients who specifically want FDA-approved branded Wegovy or Zepbound through insurance.
Pricing
$79 membership + $99 compounded semaglutide. Tirzepatide tier $278/mo.
| Signup / one-time | None |
| Membership / subscription | $79/mo |
| Medication (varies by dose) | $99–$199/mo |
| All-in, lowest maintenance dose | $178/mo |
Price since we started tracking
$178/mo, held flat across 7 weekly checks since May 2026. See the full price tracker.
See how Mochi Health compares with every path in our GLP-1 cost guide, or check the live price index for the full chart.
Lock-in & cancellation
Month-to-month
Online self-serve cancellation. No fees. Unused medication non-refundable.
Medication options
Primarily 503A-compounded for cash-pay; insurance routes to branded. Active regulatory exposure on compounded tirzepatide via Lilly litigation.
The FDA officially removed semaglutide from the drug-shortage list in February 2025, which narrowed the legal basis for routine 503A compounding of exact-copy semaglutide. Mochi Health addresses this by using a personalized-formulation model (the compound includes an additional active ingredient like vitamin B12) which is legally distinct from the FDA-approved product. The active GLP-1 molecule is the same; the regulatory framing is different. Some state pharmacy boards have tightened oversight in 2025-2026. For the full background see our compounded vs FDA-approved breakdown.
FDA-approved branded
- Wegovy (insurance only)
- Zepbound (insurance only)
Compounded
- Compounded semaglutide
- Compounded tirzepatide
Other medications
- Metformin
- Bupropion-naltrexone
- Active in Lilly's 2025-2026 lawsuit against compounded tirzepatide pharmacies
- Lost a partner pharmacy in 2025 to FDA enforcement on unsafe compounding
Read the buyer's guide for the medications Mochi Health covers: compounded semaglutide, compounded tirzepatide.
Where it's compounded
| Pharmacy | Empower Pharmacy (Houston TX), Strive Pharmacy (Gilbert AZ) |
| Regulatory model | 503A (state-licensed, patient-specific prescriptions) |
| State | TX, AZ |
| Accreditation | Empower: PCAB accredited, ships 50 states; Strive: received AZ pharmacy board scrutiny Sep 2025 |
| Disclosure | Disclosed to patients only |
Pharmacy identity confirmed via Eli Lilly tirzepatide litigation and patient reports, not published on Mochi's public site. Mochi lost a partner pharmacy in 2025 to FDA enforcement on unsafe compounding.
For background on 503A vs 503B regulation and how to vet a compounding pharmacy, see Which pharmacy compounds your GLP-1, and why it matters.
Onboarding experience
Time to first prescription: 3 days.
Consultation type: Live video visit with an obesity-medicine clinician.
Requirements: Weight, medical history, video visit. No lab work required at sign-up..
Mochi Health reviews: what members report
Reddit threads on r/Mochi_Health and r/glp1 are largely positive on price transparency and clinician quality, with skepticism around compounded sourcing post-2025 enforcement.
What works
- Price transparency at every dose
- Clinician quality on video visits
- No surprise upgrades when increasing dose
What to watch
- Pharmacy supply gaps in early 2026
- Concern about partner-pharmacy shutdown for unsafe compounding (2025)
- Shipping delays during demand spikes
How we scored Mochi Health
Five dimensions, ten points each, weighted equally. Overall is the simple average.
Transparency
Terms
Experience
Options
Reviews
Member reviews reflects Mochi Health’s Trustpilot rating of 4.5/5. See it on Trustpilot →
Frequently asked questions
Is Mochi Health legit?
Is Mochi Health a scam?
Is the compounded GLP-1 from Mochi the same as Wegovy or Ozempic?
Can I cancel Mochi anytime?
Does Mochi accept insurance?
What happens if Mochi's compounded supply gets pulled?
Alternatives to Mochi Health
If Mochi Health isn't the right fit, here are three programs we'd consider as next options:
Before committing to a cash-pay path, check whether your insurance covers a GLP-1 at the payer coverage center. On Medicaid, see Medicaid GLP-1 coverage by state first. If you need PA paperwork, the prior authorization letter library has templates for all major plans. Already denied? The appeal letter library has 120 templates by denial reason.
Direct head-to-head comparisons
Learn the category before you commit
Read these before signing up for any GLP-1 telehealth program, Mochi Health included:
Before committing to a cash-pay path, check whether your insurance covers GLP-1s at the payer coverage center. On Medicaid? See Medicaid GLP-1 coverage by stateto confirm your state’s formulary status before choosing a cash-pay program.
Similar programs
The three programs closest to Mochi Health on insurance model, medication supply and overall score, for comparison before you commit.
